References in periodicals archive ?
This is the second of our patients whose fossa ovalis-type atrial septal defect was discovered in such a serendipitous fashion.
cTGA--corrected transposition of great arteries, DC--dextrocardia, DILV-double inlet left ventricle, DIRV--double inlet right ventricle DORV--double outlet right ventricle, DSVC--double superior vena cava, EA--Ebstein anomaly, hLV--hypoplastic left ventricle, hPA--hypoplastic pulmonary arteries, hRV--hypoplastic right ventricle, LAI--left atrial isomerism, IASD--large atrial septal defect.
They are particularly associated with atrial septal defects and with severe atrioventricular valve regurgitation.
Atrial septal defect (ASO) transcatheter occlusion techniques have become a successful alternative to surgical procedures (1).
The GORE HELEX Septal Occluder became widely available in the US in 2007 and is FDA approved for the treatment of Atrial Septal Defects (ASD), congenital heart defects that often involve young children.
Chief of Cardiology, successfully closed five atrial septal defects in children at the Medical University of Hannover in Germany.
The cabinet-based system will be deployed to store, track, and manage the utilization of high cost implantable devices used to treat patients with congenital heart problems such as atrial septal defects, ventricular septal defects, and heart and pulmonary valve replacements.
from Miami Children's Hospital, Miami, Florida, reported the initial results from a multi-center North American clinical trial for use of the CardioSEAL for transcatheter closure of isolated secundum atrial septal defects ("ASD") in patients considered to be candidates for open heart surgical repair.
The clinical data from the prospective multi-center BEST (BioSTAR[R] Evaluation STudy) trial, published in the October 2006 edition of the peer-reviewed journal Circulation, demonstrated that BioSTAR[R] provides a more rapid and complete closure of atrial septal defects, with a 92% closure rate at 30 days and 96% at six months.
The ACUSON AcuNav[TM] ultrasound catheter family enables improved access during closure of atrial septal defects on smaller patients and left heart applications for both interventional cardiology and electrophysiology.
Ziyad Hijazi, highlights the improvements the organization has seen in capturing charges related to the utilization of devices and supplies for procedures treating atrial septal defects.
In partnership with leading electrophysiologists and interventional cardiologists, Dave's team developed and expanded the clinical adoption of ICE for guidance of advanced catheter-based cardiac treatments for atrial fibrillation and atrial septal defects, leading to a five-fold increase of installed customer sites and catheter sales revenue during the last four years.
Continued development and testing of a series of implantable devices including an MRI visible vena cava filter, MRI visible heart valve, MRI compatible occluder for atrial septal defects, and MRI visible stents;